Kara E. Geisel

Array ( [id] => 4190810 [patent_doc_number] => 06153639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Ethylene glycol esters as photoactive agents' [patent_app_type] => 1 [patent_app_number] => 9/313106 [patent_app_country] => US [patent_app_date] => 1999-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 5658 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153639.pdf [firstpage_image] =>[orig_patent_app_number] => 313106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944684 [patent_doc_number] => 05990160 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase' [patent_app_type] => 1 [patent_app_number] => 9/312733 [patent_app_country] => US [patent_app_date] => 1999-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3691 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990160.pdf [firstpage_image] =>[orig_patent_app_number] => 312733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4123777 [patent_doc_number] => 06127154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof' [patent_app_type] => 1 [patent_app_number] => 9/303656 [patent_app_country] => US [patent_app_date] => 1999-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10663 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127154.pdf [firstpage_image] =>[orig_patent_app_number] => 303656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384515 [patent_doc_number] => 06262119 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Methods of treating immunopathologies using polyunsaturated fatty acids' [patent_app_type] => 1 [patent_app_number] => 9/171095 [patent_app_country] => US [patent_app_date] => 1999-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 46 [patent_no_of_words] => 15007 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262119.pdf [firstpage_image] =>[orig_patent_app_number] => 171095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240040 [patent_doc_number] => 06080762 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Pulmonary and nasal delivery of raloxifene' [patent_app_type] => 1 [patent_app_number] => 9/288446 [patent_app_country] => US [patent_app_date] => 1999-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3924 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080762.pdf [firstpage_image] =>[orig_patent_app_number] => 288446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7643812 [patent_doc_number] => 06429228 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Local anesthetic for external use' [patent_app_type] => B1 [patent_app_number] => 09/284124 [patent_app_country] => US [patent_app_date] => 1999-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4398 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429228.pdf [firstpage_image] =>[orig_patent_app_number] => 09284124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109948 [patent_doc_number] => 06057360 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Compositions and systems for the treatment of hyperpigmentation' [patent_app_type] => 1 [patent_app_number] => 9/286405 [patent_app_country] => US [patent_app_date] => 1999-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2229 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057360.pdf [firstpage_image] =>[orig_patent_app_number] => 286405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220147 [patent_doc_number] => 06040301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Oral liquid antidepressant solution' [patent_app_type] => 1 [patent_app_number] => 9/283945 [patent_app_country] => US [patent_app_date] => 1999-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2232 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040301.pdf [firstpage_image] =>[orig_patent_app_number] => 283945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4193267 [patent_doc_number] => 06043259 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Treatment of cardiovascular and related pathologies' [patent_app_type] => 1 [patent_app_number] => 9/276280 [patent_app_country] => US [patent_app_date] => 1999-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7296 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043259.pdf [firstpage_image] =>[orig_patent_app_number] => 276280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4156984 [patent_doc_number] => 06114326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Use of cabergoline in the treatment of restless legs syndrome' [patent_app_type] => 1 [patent_app_number] => 9/275739 [patent_app_country] => US [patent_app_date] => 1999-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9886 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114326.pdf [firstpage_image] =>[orig_patent_app_number] => 275739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179850 [patent_doc_number] => 06037358 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Decongestant/antihistaminic compositions' [patent_app_type] => 1 [patent_app_number] => 9/275121 [patent_app_country] => US [patent_app_date] => 1999-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1233 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037358.pdf [firstpage_image] =>[orig_patent_app_number] => 275121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096463 [patent_doc_number] => 06096723 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => '4,7-dichlorofluorescein dyes as molecular probes' [patent_app_type] => 1 [patent_app_number] => 9/273655 [patent_app_country] => US [patent_app_date] => 1999-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6948 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096723.pdf [firstpage_image] =>[orig_patent_app_number] => 273655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185149 [patent_doc_number] => 06150407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Methods for inhibiting angiogenesis' [patent_app_type] => 1 [patent_app_number] => 9/274813 [patent_app_country] => US [patent_app_date] => 1999-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 12618 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150407.pdf [firstpage_image] =>[orig_patent_app_number] => 274813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4350772 [patent_doc_number] => 06214866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Composition comprising mupirocin and chlorhexidine' [patent_app_type] => 1 [patent_app_number] => 9/230756 [patent_app_country] => US [patent_app_date] => 1999-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1875 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214866.pdf [firstpage_image] =>[orig_patent_app_number] => 230756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248141 [patent_doc_number] => 06136804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions' [patent_app_type] => 1 [patent_app_number] => 9/267287 [patent_app_country] => US [patent_app_date] => 1999-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10829 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136804.pdf [firstpage_image] =>[orig_patent_app_number] => 267287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384101 [patent_doc_number] => 06262093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Methods of treating cancer with benzimidazoles' [patent_app_type] => 1 [patent_app_number] => 9/264942 [patent_app_country] => US [patent_app_date] => 1999-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13622 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262093.pdf [firstpage_image] =>[orig_patent_app_number] => 264942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320542 [patent_doc_number] => 06248752 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Azabicyclooctane compositions and methods for enhancing chemotherapy' [patent_app_type] => 1 [patent_app_number] => 9/257829 [patent_app_country] => US [patent_app_date] => 1999-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4916 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248752.pdf [firstpage_image] =>[orig_patent_app_number] => 257829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640134 [patent_doc_number] => 06395781 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => '20-HETE antagonists and agonists' [patent_app_type] => B1 [patent_app_number] => 09/259414 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 18783 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395781.pdf [firstpage_image] =>[orig_patent_app_number] => 09259414 [rel_patent_id] =>[rel_patent_doc_number] =>)